Details for 2020192145

Up to date per 14.05.2026

Actions

Title / Product Name

OPTIMIERUNG VON ANTIKÖRPERN ZUR BINDUNG DES LYMPHOZYTENAKTIVIERUNGSGENS 3 (LAG-3) UND VERWENDUNGEN DAVON

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020192145

EP Publication Number

3795592

E-Number

1705695

Language

PCT Number

Publication Date

24.03.2021 A

24.07.2024 B1

Registration Date

24.07.2024

AT Publication Date

15.08.2024

Application Date

02.07.2013

Registration Number

Priorities

02.07.2012

201261667058 P

IPC

A61K 45/06 20060101AFI20240131BHEP

Maximum Duration of Protection

02.07.2033

Owner

Bristol-Myers Squibb CompanyRoute 206 and Province Line Road Princeton, NJ 08543US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

LONBERG, Nilsc/o Bristol-Myers Squibb Company 700 Bay Road Redwood City, CA 94063US

SRINIVASAN, Mohanc/o Bristol-Myers Squibb Company 700 Bay Road Redwood City, CA 94063US

Information about Fees